Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA’s Marks Was Frustrated About Slow Completion Of 2021 Comirnaty Review
Jan 25 2023
•
By
Derrick Gingery
OVRR officials initially proposed completing the Comirnaty BLA review by 15 September 2021. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Vaccines
More from Pink Sheet